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MATERIAL
Determinations of pyruvic acid in the blood, spinal fluid, and urine were made by means of the Lu method (1) as modified by Friedemann and Haugen (2) .
A control group of 16 surgical and orthopedic patients suffering only from mechanical disabilities was employed. A series of 31 patients without liver disease was also studied; the diagnoses in this group included renal, neurological, and gastrointestinal diseases and infections of various kinds. For reasons which will be discussed, a group of 13 patients with pulmonary emphysema was included. Thirty-five patients with liver disease, including 12 with viral hepatitis and 23 with decompensated portal cirrhosis, were studied. These patients were placed on a diet of 3,000 calories per day (C-350, P-150, F-100) with daily parenterally administered vitamins which included 110 mgm of thiamine, 100 mgm of ascorbic acid, 10 mgm of menadione, 5 mgm of pyridoxine, 50 mgm of pantothenic acid, and 250 mgm of niacin. All patients were on 24 hours of bed rest so as to avoid the effect of exercise which in itself will cause a slight increase in the blood pyruvic acid. Twelve of these were observed during acute hepatic failure as manifested by hepatic coma (seven with portal cirrhosis and five with homologous serum jaundice). The patients in coma received a minimal daily caloric intake of 3,000 calories by gastric intubation.
RESULTS
In the control group the mean values of pyruvic acid were 1.04 0.088 mgm% in the fasting blood and 1.02 + 0.003 mgm% in the fasting (3) and by Friedemann and Haugen (4) . In patients with viral hepatitis, excluding those who were most severely ill and in hepatic coma (to be discussed separately), the pyruvic acid determinations of the blood showed no significant statistical difference when compared with the control group. However, in patients with greatly impaired hepatic function including those with portal cirrhosis and those in hepatic Table I . The increase in these values compared to the control group was found to be statistically significant. The blood pyruvic acid was followed over a period of time in patients with decompensated cirrhosis and a return to normal in from four to five days was noted (Figure 1 ).
Twelve patients were studied during periods of hepatic coma characterized by neurological manifestations including mental confusion, listlessness or agitation, disorientation, somnolence, and profound coma. Neurological findings included hyporeflexia, absent response to painful stimuli, presence of sucking reflex, positive Babinski response, and fecal and urinary incontinence. Oliguria or anuria was a constant feature. All patients had marked alteration in all of the usual liver function tests including fractional serum bilirubin, cephalin cholesterol flocculation, thymol turbidity, zinc sulfate turbidity, alkaline phosphatase, total cholesterol with esters, plasma protein value including albumin-globulin ratio, 24-hour urine urobilinogen, and prothrombin time. The diagnosis was confirmed at necropsy in 11 of these patients.
In hepatic coma pyruvic acid determinations were made on the fasting blood and spinal fluid, and on breath samples collected in distilled water Figure 2 illustrates Table I for mean values.) A comparison of these values with the control group revealed no statistically significant difference in the blood pyruvic acid. It is apparent that decreased arterial oxygen saturation of from 93%o to 51%o has no effect on the pyruvic acid of the blood. It is also apparent that if this degree of hypoxia exists in liver failure, it would have no effect on the pyruvic acid values in the blood.
Finally, the pyruvic acid values of the three groups of liver disease were compared. A definite statistically significant difference of the blood pyruvic acid values was found between the group with viral hepatitis (exclusive of coma) and that with portal cirrhosis; this was also true between the group with viral hepatitis and that with hepatic coma. A comparison of the group with portal cirrhosis and that with hepatic coma revealed a statistically significant difference of the blood pyruvic acid values (Table III) . From these findings one may conclude that the degree of elevation of the blood pyruvic acid is dependent upon the degree of hepatic failure.
DISCUSSION
In the metabolism of carbohydrates, pyruvic acid occupies a central position and the reactions in this metabolic breakdown are reversible. Pyruvic acid is also a link between the metabolism of carbohydrate and protein.
Under normal conditions pyruvic acid may contribute to the formation of carbohydrate and may undergo reversible and irreversible transformation. The irreversible transformations are an oxidative decarboxylation and a complete oxidation under aerobic conditions. The reversible transformations are a reduction to lactic acid and a transamination to alanine under anaerobic conditions. Pyruvic acid incubated with liver tissue gives rise to oxalacetic, alpha ketoglutaric, succinic, fumaric, and citric acids (7) . The formation of oxalacetic acid is dependent upon the CO2 fixation of pyruvic acid, and this has been shown to occur in the liver (8) .
Pyruvic acid has been found to be elevated in the blood of patients with thiamine deficiency (9), alcoholic polyneuritis (3), thyrotoxicosis (10), heart failure ( 11 ), and after severe exercise. The elevation of the pyruvic acid in beri-beri, alcoholic polyneuritis, and thyrotoxicosis is due to thiamine deficiency. After severe exercise its elevation is due to a sudden release from an increased metabolic breakdown of glucose by muscle. Snell and Butt (12) have reported increased values of pyruvic acid in the blood of two patients with liver diseases who were in hepatic coma and suggested that they may result from a breakdown of certain enzyme systems (cozymase and co-carboxylase) which play a part in intermediary metabolism of glucose. In heart failure the elevation of the pyruvic acid may be related to impaired liver function due to congestion.
Factors producing the elevated pyruvic acid in liver failure are not known. It would appear that it is not due to a simple vitamin deficiency since pyruvic acid values rise steadily in progressive hepatic failure in spite of parenteral administration of large amounts of vitamins. It can only be suggested that the elevated pyruvic acid may be due to an inability of the liver to assimilate pyruvic acid to form the dicarboxylic acids necessary for the Krebs cycle. Failure of cellular aerobic metabolism may well explain the neurological manifesta- 
